Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Adeniyi Oyebade

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Graduate Student

Also affiliated: Adeyemi Federal University of Education, Ondo, Nigeria (2025)

4 h-index 9 pubs 56 cited

  • Nanomedicine
  • Doxorubicin
  • Endocytosis
  • Humans
  • MCF-7 Cells
  • Antineoplastic Agents
  • Macrocyclic Compounds
  • Histone Deacetylase Inhibitors
  • Antibiotics, Antineoplastic
  • Biocompatible Materials
  • Cell Survival
  • Drug Screening Assays, Antitumor
  • Ions
  • Materials Testing
  • Particle Size

Biography and Research Information

OverviewAI-generated summary

Adeniyi Oyebade's research focuses on the development and application of nanomedicines for cancer therapy and antimicrobial applications. His work includes the creation of doxorubicin-based ionic nanomedicines designed for combined chemo-phototherapy and investigating the role of endocytosis pathways in their efficacy. Oyebade has also explored the use of macrocyclic histone deacetylase inhibitor-based nanomedicines for near-infrared-responsive cancer treatment. Additionally, his research encompasses the development of antibiotic-coupled therapies for enhanced bacterial killing and the targeted delivery of drugs like rapamycin via epidermal growth factor receptors for pancreatic cancer treatment. He has published nine papers, accumulating 56 citations, and holds an h-index of 4. Oyebade collaborates with researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Nawab Ali, and Mavis Forson.

Metrics

  • h-index: 4
  • Publications: 9
  • Citations: 56

Positions

  • Graduate Student 2022–present
    University of Arkansas at Little Rock Chemistry ORCID

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex
  • Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
    Batteries 10 citations DOI OpenAlex
  • Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
    ACS Omega 1 citation DOI OpenAlex
  • Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025)
    European Journal of Theoretical and Applied Sciences DOI OpenAlex
  • IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
    PubMed DOI OpenAlex
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    ACS Applied Bio Materials 6 citations DOI OpenAlex
  • Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
    Applied Spectroscopy Reviews 28 citations DOI OpenAlex
  • Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
    ACS Applied Nano Materials 9 citations DOI OpenAlex
  • Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
    Journal Of Biochemical Technology 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

48 Collaborators 16 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics